Full Description
First published in 1993, the Role of Beta Receptor Agonist Therapy in Asthma Mortality provides the first comprehensive review of the role of beta-receptor agonist drug therapy and asthma mortality. The book includes sections on the epidemiological and experimental methods used to examine possible relationships between beta-agonist drug therapy and asthma mortality. It also reviews the development of beta-agonist drugs and the long-term trends in asthma mortality to present a historical perspective. Internationally respected experts have contributed to this unique volume, making it essential for epidemiologists, pharmacologists, and researchers in clinical medicine and public health.
Contents
Preface. Historical OverviewDrugs (S.R. O'Donnell). Studies of Time Trends in Asthma Mortality: A Century of Asthma Mortality (R.T. Jackson). Asthma Mortality Epidemics: The Problem Approached Epidemiologically (P. Stolley and T. Lasky). Analytical Epidemiological Studies of Beta Receptor Agonist Therapy and Asthma Mortality: Epidemiological Methods for Studying the Role of Beta Receptor Agonist Therapy in Asthma Mortality (N.E. Pearce and J.Crane). The New Zealand Case-Control Studies of Asthma Deaths Fenoterol: Interpratation and Clinical and Drug Regulatory Implications (J.M. Elwood). The Pharmacological Effects of Beta Receptor Agonist Drugs: An Overview of Experimental Methods (C.D. Burgess). The Role of Hypoxemia in Determining the Cardiovascular Response to Beta Receptor Agonist Drugs (R.G. Shanks). The Acute and Long-Term Effects of Beta Receptor Agonist Therapy: The Acute Unwanted Effects of Beta2 Receptor Agonist Therapy (M.J. Kendall and C.A. Haffner). The Long Term Effects of Beta Receptor Agonist Therapy in Relation to Morbidity and Mortality (C.S. Wong and A.E. Tattersfield). The Future: Long-Acting Inhaled Beta2 Receptor Agonist Drugs (K.F. Chung and P.J. Barnes). Asthma Mortality and Beta Receptor Agonists-A Perspective (J. Crane).
